Your browser doesn't support javascript.
loading
Type I interferon signaling facilitates resolution of acute liver injury by priming macrophage polarization.
Song, Qiaoling; Datta, Shyamasree; Liang, Xue; Xu, Xiaohan; Pavicic, Paul; Zhang, Xiaonan; Zhao, Yuanyuan; Liu, Shan; Zhao, Jun; Xu, Yuting; Xu, Jing; Wu, Lihong; Wu, Zhihua; Zhang, Minghui; Zhao, Zhan; Lin, Chunhua; Wang, Yuxin; Han, Peng; Jiang, Peng; Qin, Yating; Li, Wei; Zhang, Yingying; Luo, Yonglun; Sen, Ganes; Stark, George R; Zhao, Chenyang; Hamilton, Thomas; Yang, Jinbo.
Afiliação
  • Song Q; Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
  • Datta S; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Liang X; Lars Bolund Institute of Regenerative Medicine, Qingdao-Europe Advanced Institute for Life Sciences, BGI-Qingdao, BGI-Shenzhen, Shenzhen, China.
  • Xu X; Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
  • Pavicic P; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Zhang X; Innovation Center of Marine Drug Screening & Evaluation, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China.
  • Zhao Y; Department of Radiation, Affiliated Hospital of Qingdao University, Qingdao, China.
  • Liu S; Innovation Center of Marine Drug Screening & Evaluation, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China.
  • Zhao J; Innovation Center of Marine Drug Screening & Evaluation, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China.
  • Xu Y; Innovation Center of Marine Drug Screening & Evaluation, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China.
  • Xu J; Innovation Center of Marine Drug Screening & Evaluation, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China.
  • Wu L; Innovation Center of Marine Drug Screening & Evaluation, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China.
  • Wu Z; Innovation Center of Marine Drug Screening & Evaluation, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China.
  • Zhang M; Innovation Center of Marine Drug Screening & Evaluation, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China.
  • Zhao Z; Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
  • Lin C; Department of Urology, Yantai Yuhuangding Hospital, Yantai, China.
  • Wang Y; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Han P; Lars Bolund Institute of Regenerative Medicine, Qingdao-Europe Advanced Institute for Life Sciences, BGI-Qingdao, BGI-Shenzhen, Shenzhen, China.
  • Jiang P; Department of Radiation, Affiliated Hospital of Qingdao University, Qingdao, China.
  • Qin Y; Lars Bolund Institute of Regenerative Medicine, Qingdao-Europe Advanced Institute for Life Sciences, BGI-Qingdao, BGI-Shenzhen, Shenzhen, China.
  • Li W; Department of Radiation, Affiliated Hospital of Qingdao University, Qingdao, China.
  • Zhang Y; Lars Bolund Institute of Regenerative Medicine, Qingdao-Europe Advanced Institute for Life Sciences, BGI-Qingdao, BGI-Shenzhen, Shenzhen, China.
  • Luo Y; Lars Bolund Institute of Regenerative Medicine, Qingdao-Europe Advanced Institute for Life Sciences, BGI-Qingdao, BGI-Shenzhen, Shenzhen, China.
  • Sen G; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Stark GR; Department of Cancer Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • Zhao C; Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China. zhaochenyang2021@gmail.com.
  • Hamilton T; Innovation Center of Marine Drug Screening & Evaluation, Qingdao National Laboratory for Marine Science and Technology, Qingdao, China. zhaochenyang2021@gmail.com.
  • Yang J; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA. hamiltt@ccf.org.
Cell Mol Immunol ; 20(2): 143-157, 2023 02.
Article em En | MEDLINE | ID: mdl-36596875
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Hepática Induzida por Substâncias e Drogas / Acetaminofen Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença Hepática Induzida por Substâncias e Drogas / Acetaminofen Idioma: En Ano de publicação: 2023 Tipo de documento: Article